Literature DB >> 26901756

Hyaluronic acid modified mesoporous carbon nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.

Long Wan1, Jian Jiao, Yu Cui, Jingwen Guo, Ning Han, Donghua Di, Di Chang, Pu Wang, Tongying Jiang, Siling Wang.   

Abstract

In this paper, hyaluronic acid (HA) functionalized uniform mesoporous carbon spheres (UMCS) were synthesized for targeted enzyme responsive drug delivery using a facile electrostatic attraction strategy. This HA modification ensured stable drug encapsulation in mesoporous carbon nanoparticles in an extracellular environment while increasing colloidal stability, biocompatibility, cell-targeting ability, and controlled cargo release. The cellular uptake experiments of fluorescently labeled mesoporous carbon nanoparticles, with or without HA functionalization, demonstrated that HA-UMCS are able to specifically target cancer cells overexpressing CD44 receptors. Moreover, the cargo loaded doxorubicin (DOX) and verapamil (VER) exhibited a dual pH and hyaluronidase-1 responsive release in the tumor microenvironment. In addition, VER/DOX/HA-UMCS exhibited a superior therapeutic effect on an in vivo HCT-116 tumor in BALB/c nude mice. In summary, it is expected that HA-UMCS will offer a new method for targeted co-delivery of drugs to tumors overexpressing CD44 receptors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26901756     DOI: 10.1088/0957-4484/27/13/135102

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  9 in total

Review 1.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

Review 2.  Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.

Authors:  Nader Salari; Kamran Mansouri; Elahe Valipour; Farzaneh Abam; Mehdi Jaymand; Shna Rasoulpoor; Sadat Dokaneheifard; Masoud Mohammadi
Journal:  Daru       Date:  2021-09-09       Impact factor: 4.088

3.  Engineered pH-Responsive Mesoporous Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Julia C Berkmann; Dimitra Giasafaki; Daniel Lozano; Konstantinos Spyrou; Miguel Manzano; Theodore Steriotis; Georg N Duda; Katharina Schmidt-Bleek; Georgia Charalambopoulou; María Vallet-Regí
Journal:  ACS Appl Mater Interfaces       Date:  2020-03-17       Impact factor: 9.229

Review 4.  Mesoporous Carbon: A Versatile Material for Scientific Applications.

Authors:  Md Motiar Rahman; Mst Gulshan Ara; Mohammad Abdul Alim; Md Sahab Uddin; Agnieszka Najda; Ghadeer M Albadrani; Amany A Sayed; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 5.  Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Authors:  Panoraia I Siafaka; Neslihan Üstündağ Okur; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

6.  Tumor Microenvironment Targeted Nanotherapy.

Authors:  Clara Fernandes; Divya Suares; Mayur C Yergeri
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

Review 7.  Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers.

Authors:  Hongli Yan; Zhifeng Xue; Jiarong Xie; Yixiao Dong; Zhe Ma; Xinru Sun; Dereje Kebebe Borga; Zhidong Liu; Jiawei Li
Journal:  Int J Nanomedicine       Date:  2019-12-31

8.  Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.

Authors:  Yurui Xu; Sajid Asghar; Shiya Gao; Zhipeng Chen; Lin Huang; Lining Yin; Qineng Ping; Yanyu Xiao
Journal:  Int J Nanomedicine       Date:  2017-10-10

Review 9.  Mesoporous carbon nanomaterials in drug delivery and biomedical application.

Authors:  Qinfu Zhao; Yuanzhe Lin; Ning Han; Xian Li; Hongjian Geng; Xiudan Wang; Yu Cui; Siling Wang
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.